Research Centres and Consortia
The Research carried out at Statens Serum Institut (SSI) is of a high international standard. Several international research centres, consortia and research partnerships are established with SSI either as coordinator or as participant.
-
Center for Nano-Vaccine
- Tuberculosis Vaccine Initiative (TBVI)
- NEWTBVAC - Discovery and preclinical development of new generation tuberculosis vaccines
- EPI-Expose therapeutic Vaccine Platform
- EDCTP - Conduct of ICH-GCP level Phase II TB vaccine trails in high rist populations in Africa
- Gates GC12 - Preclinical and clinical evaluation of post-exposure TB vaccine
- FastVac
More information about the above consortia / collaborations, click here Funded Projects - consortia - research collaborations
- InterLymph
- The Early Nutrition Programming Project (EARNEST)
- VAESCO
- Infectious Diseases in Greenland - a Network Organisation
- EuroMOMO – European Monitoring of Excess Mortality for Public Health Action
- EUVAC.NET – European surveillance network for vaccine-preventable diseases
- Sero-epidemiology as a tool to assess incidence of Salmonella and Campylobacter infec-tions
- Influenza - Monitoring Vaccine Effectiveness
- Indepth Network
More information about the above consortia / collaborations, click here Epidemiology Research Consortia
Last revised 26 August 2010